The Objective of This Study is to Evaluate the Efficacy and Safety of Botulax® in Patients With Essential Blepharospasm.
Clinical trial NCT03641950 · COMPLETED
Trial details
- NCT number
- NCT03641950
- Sponsor
- Hugel
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-30
- Primary completion
- 2015-05-01
- Enrollment
- 249
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.